1. Home
  2. CLMB vs TENX Comparison

CLMB vs TENX Comparison

Compare CLMB & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CLMB

Climb Global Solutions Inc.

HOLD

Current Price

$24.26

Market Cap

387.6M

Sector

Technology

ML Signal

HOLD

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$16.53

Market Cap

317.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLMB
TENX
Founded
1982
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
387.6M
317.8M
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
CLMB
TENX
Price
$24.26
$16.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$80.00
$29.67
AVG Volume (30 Days)
173.4K
1.3M
Earning Date
04-29-2026
05-15-2026
Dividend Yield
0.60%
N/A
EPS Growth
14.29
N/A
EPS
0.18
N/A
Revenue
$652,517,000.00
N/A
Revenue This Year
$7.82
N/A
Revenue Next Year
$5.83
N/A
P/E Ratio
$132.56
N/A
Revenue Growth
40.14
N/A
52 Week Low
$15.25
$5.76
52 Week High
$145.00
$18.38

Technical Indicators

Market Signals
Indicator
CLMB
TENX
Relative Strength Index (RSI) 58.33 71.75
Support Level $18.97 $12.84
Resistance Level $25.12 $18.38
Average True Range (ATR) 1.30 1.00
MACD 0.24 0.45
Stochastic Oscillator 83.27 98.00

Price Performance

Historical Comparison
CLMB
TENX

About CLMB Climb Global Solutions Inc.

Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, United Kingdom, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

Share on Social Networks: